Kangbuk Samsung Medical Center

Seoul 110746

0 studies enrolling now · 3 studies all time

What they study most

Intermittent Claudication, Non-Small Cell Lung Cancer, Peripheral Artery Disease, Ulcerative Colitis

Studies at this site

• A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer — Completed
• Efficacy and Safety Study of Ozanimod in Ulcerative Colitis — Completed
• Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) — Completed